Clinical Pharmacology Studies Supporting Oligonucleotide Therapy Development: An Assessment of Therapies Approved and in Development Between 2012 and 2018
Synthetic nucleotides that utilize RNA‐centric pharmacology can target diseases at the RNA level, thus altering protein expression in ways previously inaccessible to small molecules and therapeutic biologics. Recognizing that the unique pharmacology of oligonucleotides may require specific considera...
Saved in:
Main Authors: | Hobart Rogers (Author), Oluseyi Adeniyi (Author), Anuradha Ramamoorthy (Author), Samantha Bailey (Author), Michael Pacanowski (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oligonucleotide, Therapy, and Applications
Published: (2022) -
Clinical pharmacology information in regulatory submissions and labeling: A comparative analysis of orphan and non‐orphan drugs approved by the FDA
by: Julie Hsieh, et al.
Published: (2022) -
Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024) -
Kymriah® (tisagenlecleucel) - An overview of the clinical development journey of the first approved CAR-T therapy
by: Rakesh Awasthi, et al.
Published: (2023) -
Antisense Oligonucleotide-Based Therapy of Viral Infections
by: Woan-Yuh Tarn, et al.
Published: (2021)